Veracyte reported $-941000 in EBITDA for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Agenus AGEN:US $ -43.28M 8.94M
Agilent A:US $ 514M 48M
Arrowhead Research ARWR:US $ -70306000 114.46M
Biocept BIOC:US $ -2.3M 0.02M
Bruker BRKR:US $ 107.6M 17.5M
Exact Sciences EXAS:US $ -101.13M 28.2M
Illumina ILMN:US $ 124M 151M
Karyopharm Therapeutics KPTI:US $ -42759000 8.35M
Laboratory Of America LH:US $ 751.4M 111.8M
Myriad Genetics MYGN:US $ -4.8M 2.9M
Sangamo Biosciences SGMO:US $ -42.85M 0.42M
Siemens SIE:GR € 3311M 1009M
Sonic Healthcare SHL:AU $ 1.29B 248.31M
Thermo Fisher Scientific TMO:US $ 2861M 821M
Veracyte VCYT:US $ -0.94M 7.75M
Waters WAT:US $ 233.88M 5.74M